Survivors who have received a blood or marrow transplant (BMT) require life-long follow-up care and support, however evidence-based assessments of long-term models of care are scarce. This qualitative descriptive study explored the perspectives of blood and marrow transplant (BMT) specialist nurses and physicians, and General Practitioners (GPs) regarding the long-term management and follow-up care of BMT survivors.
Australia’s National Clinical Guidelines for Acute Myeloid Leukaemia (AML), developed by and for the Australian haematology community to provide expert-driven, evidence-based treatment recommendations, are now available.
